Dudediligence.

Corcept Therapeutics Incorporated

CORTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$182.5MSep ’24$181.9MDec ’24$157.2MMar ’25$194.4MJun ’25$207.6MSep ’25$202.1MDec ’25$164.9MMar ’26$256.1MJun ’26
Net income, by quarter
$47.2MSep ’24$30.7MDec ’24$20.5MMar ’25$35.1MJun ’25$19.7MSep ’25$24.3MDec ’25−$31.8MMar ’26$43.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$366.0M$401.9M$482.4M$675.0M$761.4M
Gross profit$360.7M$396.5M$475.9M$664.2M$748.4M
Operating income$124.5M$112.6M$107.3M$137.0M$44.8M
Net income$112.5M$101.4M$106.1M$141.2M$99.7M
Operating cash flow$167.9M$120.3M$126.7M$198.3M$142.0M
Free cash flow$167.4M$119.9M$126.5M$196.1M$141.8M
Cash$77.6M$66.3M$135.6M$127.7M$120.5M
Shares outstanding105.9M107.8M103.4M105.1M106.0M